title: Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods.
abstract: The TOM study is the first, single-site, placebo-controlled, randomized clinical trial designed to comprehensively determine the effects of testosterone administration on muscle strength and physical function in older men with mobility limitations. A total of 252 community dwelling individuals aged 65 and older with low testosterone levels and self-reported limitations in mobility and short physical performance battery (SPPB) scores between 4 and 9 will be randomized to receive either placebo or testosterone therapy for 6 months. The primary objective is to determine whether testosterone therapy improves maximal voluntary muscle strength as quantified by the one repetition maximum. Secondary outcomes will include measures of physical function (walking, stair climbing and a lifting and lowering task), habitual physical activity and self-reported disability. The effects of testosterone on affect, fatigue and sense of well being will also be assessed. Unique aspects of the TOM Trial include selection of men with self-reported as well as objectively demonstrable functional limitations, community-based screening and recruitment, adjustment of testosterone dose to ensure serum testosterone levels in the target range while maintaining blinding, and inclusion of a range of self-reported and performance-based physical function measures as outcomes. Clinicaltrials.gov identifier: NCT00240981.
authors.affiliation: Department of Medicine, Boston University Medical Center, Boston, MA 02118, United States.
authors.forename: Nathan K
authors.initials: NK
authors.lastname: LeBrasseur
authors.forename: Newsha
authors.initials: N
authors.lastname: Lajevardi
authors.forename: Renee
authors.initials: R
authors.lastname: Miciek
authors.forename: Norman
authors.initials: N
authors.lastname: Mazer
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Storer
authors.forename: Shalender
authors.initials: S
authors.lastname: Bhasin
mesh_terms: D000279:Administration, Cutaneous; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000728:Androgens / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005080:Exercise Test; D005782:Gels; D006304:Health Status; D006305:Health Status Indicators; D006801:Humans; D035002:Lower Extremity; D008297:Male; D051346:Mobility Limitation; D009119:Muscle Contraction / Q000187:drug effects; D053580:Muscle Strength / Q000187:drug effects*; D018482:Muscle, Skeletal / Q000187:drug effects*; D012106:Research; D012107:Research Design; D013739:Testosterone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000728:Androgens; D005782:Gels; D013739:Testosterone